Life Sciences Market - Industry overview, Trends & Report

sale

Biosimilar Monoclonal Antibody Market

P

2023

Biosimilar Monoclonal Antibody Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global biosimilar monoclonal antibody market was valued at $8.7 billion in 2022, and is projected to reach $64.7 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.

Report Code : A03330 | Pages : 293 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Monoclonal Antibody Market

U

2026

Monoclonal Antibody Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Monoclonal antibodies are replicas of a unique parental cell derived from identical immune cells. These antibodies can bind to a particular antigen when administered, as they have monovalent ...

Report Code : A04020 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Diagnostic Specialty Antibodies Market

U

2026

Diagnostic Specialty Antibodies Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Antibodies are blood protein. Every specific antigen has a specific antibody manufactured by the body. They are generally called immunoglobulin and are usually in the shape of the ...

Report Code : A08422 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Neuroscience Antibodies and Assays Market

U

2026

Neuroscience Antibodies and Assays Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Neuroscience is a diversified sector, which needs an integrated analysis of various organs, tissues, and cell types, by the use of various techniques. The future of research and developments in the neuroscience field depends on the antibodies, assays, and immunodetection.

Report Code : A10297 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Monoclonal Antibodies Market

P

2021

Monoclonal Antibodies Market: Global Opportunity Analysis and Industry Forecast, 2021–2030

The global monoclonal antibodies market size was valued at $146,642 million in 2020, and is projected to reach $390,582 million by 2030, registering a CAGR of 10.2% from 2021 to 2030.

Report Code : A11789 | Pages : 245 | Category : Life Sciences

Price:

~~$3,712~~ $2,895 (22% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

HER2 Antibodies Market

U

2026

HER2 Antibodies Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

The human epidermal growth factor receptor 2 (HER2) is used to control the protein on the cell surface that helps the cell to grow. It belongs to the ...

Report Code : A11931 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Intravenous Antibodies Market

U

2026

Intravenous Antibodies Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Immunoglobulin refers to the breakdown of blood plasma that contains antibody and intravenous immunoglobulin (IVIG) can be defined as a blood product administered intravenously. This therapy is applicable ...

Report Code : A12480 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

North America Biosimilar Monoclonal Antibody Market

P

2023

North America Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

North America Biosimilar Monoclonal Antibody Market to showcase promising growth throughout the projection period from 2023 and 2032 owing to increased spending from emerging countries.

Report Code : * A224489 | Pages : 108 | Category : Life Sciences

Price:

~~$2,850~~ $1,995 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Biosimilar Monoclonal Antibody Market

P

2023

U.S. Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

Research study titled U.S. Biosimilar Monoclonal Antibody Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

Report Code : * A224490 | Pages : 89 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Canada Biosimilar Monoclonal Antibody Market

P

2023

Canada Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Canada Biosimilar Monoclonal Antibody Market achieved significant revenue share in base year of analysis. The Canada Biosimilar Monoclonal Antibody Market size is expected to account for a considerable growth rate between 2023 to 2032.

Report Code : * A224491 | Pages : 80 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Mexico Biosimilar Monoclonal Antibody Market

P

2023

Mexico Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The report focuses on the major industry players operating in the Mexico Biosimilar Monoclonal Antibody Market and their relative market share. End User segment dominates the Mexico Biosimilar Monoclonal Antibody Market and is expected to retain its dominance throughout the forecast period.

Report Code : * A224492 | Pages : 88 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Europe Biosimilar Monoclonal Antibody Market

P

2023

Europe Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Europe Biosimilar Monoclonal Antibody Market achieved significant revenue share in base year of analysis. The Europe Biosimilar Monoclonal Antibody Market size is expected to account for a considerable growth rate between 2023 to 2032.

Report Code : * A224493 | Pages : 113 | Category : Life Sciences

Price:

~~$2,850~~ $1,995 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

UK Biosimilar Monoclonal Antibody Market

P

2023

UK Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The UK Biosimilar Monoclonal Antibody Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The UK Biosimilar Monoclonal Antibody Market growth is attributed to various driving factors and revenue opportunities.

Report Code : * A224494 | Pages : 90 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Germany Biosimilar Monoclonal Antibody Market

P

2023

Germany Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Germany Biosimilar Monoclonal Antibody Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.

Report Code : * A224495 | Pages : 84 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

France Biosimilar Monoclonal Antibody Market

P

2023

France Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The End User has the highest CAGR over the analysis period. The section Top Winning Strategies from report provides insights about most frequently adopted strategies by key players in the market.

Report Code : * A224496 | Pages : 84 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Italy Biosimilar Monoclonal Antibody Market

P

2023

Italy Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Italy Biosimilar Monoclonal Antibody Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.

Report Code : * A224497 | Pages : 73 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Spain Biosimilar Monoclonal Antibody Market

P

2023

Spain Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

End User segment is projected to create abundant revenue opportunity till 2032. Leading players in Spain Biosimilar Monoclonal Antibody Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.

Report Code : * A224498 | Pages : 72 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Asia-Pacific Biosimilar Monoclonal Antibody Market

P

2023

Asia-Pacific Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

End User is projected as the most lucrative segment. The report provides insights based on the key determinants of the market, including drivers and challenges along with their relative impact on the regional and country level.

Report Code : * A224499 | Pages : 104 | Category : Life Sciences

Price:

~~$2,670~~ $1,869 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

South Korea Biosimilar Monoclonal Antibody Market

P

2023

South Korea Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The South Korea Biosimilar Monoclonal Antibody Market achieved significant revenue share in base year of analysis. The South Korea Biosimilar Monoclonal Antibody Market size is expected to account for a considerable growth rate between 2023 to 2032.

Report Code : * A224500 | Pages : 71 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Japan Biosimilar Monoclonal Antibody Market

P

2023

Japan Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

Leading players in Japan Biosimilar Monoclonal Antibody Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.

Report Code : * A224501 | Pages : 76 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Australia Biosimilar Monoclonal Antibody Market

P

2023

Australia Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

End User segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Australia Biosimilar Monoclonal Antibody Market due to the outbreak of COVID-19.

Report Code : * A224502 | Pages : 88 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

China Biosimilar Monoclonal Antibody Market

P

2023

China Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The China Biosimilar Monoclonal Antibody Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. The China Biosimilar Monoclonal Antibody Market report covers profile of leading stakeholders operating in the China.

Report Code : * A224503 | Pages : 90 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

India Biosimilar Monoclonal Antibody Market

P

2023

India Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

India Biosimilar Monoclonal Antibody Market is projected to experience high investment on various major technologies/product/services in India country by the end of 2032 owing to presence of key end user vertical adopting offerings at a faster pace.

Report Code : * A224504 | Pages : 76 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

LAMEA Biosimilar Monoclonal Antibody Market

P

2023

LAMEA Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The LAMEA Biosimilar Monoclonal Antibody Market achieved significant revenue share in base year of analysis. The LAMEA Biosimilar Monoclonal Antibody Market size is expected to account for a considerable growth rate between 2023 to 2032.

Report Code : * A224505 | Pages : 118 | Category : Life Sciences

Price:

~~$2,670~~ $1,869 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Brazil Biosimilar Monoclonal Antibody Market

P

2023

Brazil Biosimilar Monoclonal Antibody Market: Opportunity Analysis and Industry Forecast, 2022-2032

The End User segment in Brazil Biosimilar Monoclonal Antibody Market is expected to garner considerable share in terms of value and volume during the forecast period.

Report Code : * A224506 | Pages : 77 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Life Sciences

Filter by Region

Filter by Discounts

Filter by Category

The global biosimilar monoclonal antibody market was valued at $8.7 billion in 2022, and is projected to reach $64.7 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.

Monoclonal antibodies are replicas of a unique parental cell derived from identical immune cells. These antibodies can bind to a particular antigen when administered, as they have monovalent ...

Antibodies are blood protein. Every specific antigen has a specific antibody manufactured by the body. They are generally called immunoglobulin and are usually in the shape of the ...

Neuroscience is a diversified sector, which needs an integrated analysis of various organs, tissues, and cell types, by the use of various techniques. The future of research and developments in the neuroscience field depends on the antibodies, assays, and immunodetection.

The global monoclonal antibodies market size was valued at $146,642 million in 2020, and is projected to reach $390,582 million by 2030, registering a CAGR of 10.2% from 2021 to 2030.

The human epidermal growth factor receptor 2 (HER2) is used to control the protein on the cell surface that helps the cell to grow. It belongs to the ...

Immunoglobulin refers to the breakdown of blood plasma that contains antibody and intravenous immunoglobulin (IVIG) can be defined as a blood product administered intravenously. This therapy is applicable ...

North America Biosimilar Monoclonal Antibody Market to showcase promising growth throughout the projection period from 2023 and 2032 owing to increased spending from emerging countries.

Research study titled U.S. Biosimilar Monoclonal Antibody Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

The Canada Biosimilar Monoclonal Antibody Market achieved significant revenue share in base year of analysis. The Canada Biosimilar Monoclonal Antibody Market size is expected to account for a considerable growth rate between 2023 to 2032.

The report focuses on the major industry players operating in the Mexico Biosimilar Monoclonal Antibody Market and their relative market share. End User segment dominates the Mexico Biosimilar Monoclonal Antibody Market and is expected to retain its dominance throughout the forecast period.

The Europe Biosimilar Monoclonal Antibody Market achieved significant revenue share in base year of analysis. The Europe Biosimilar Monoclonal Antibody Market size is expected to account for a considerable growth rate between 2023 to 2032.

The UK Biosimilar Monoclonal Antibody Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The UK Biosimilar Monoclonal Antibody Market growth is attributed to various driving factors and revenue opportunities.

The Germany Biosimilar Monoclonal Antibody Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.

The End User has the highest CAGR over the analysis period. The section Top Winning Strategies from report provides insights about most frequently adopted strategies by key players in the market.

The Italy Biosimilar Monoclonal Antibody Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.

End User segment is projected to create abundant revenue opportunity till 2032. Leading players in Spain Biosimilar Monoclonal Antibody Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.

End User is projected as the most lucrative segment. The report provides insights based on the key determinants of the market, including drivers and challenges along with their relative impact on the regional and country level.

The South Korea Biosimilar Monoclonal Antibody Market achieved significant revenue share in base year of analysis. The South Korea Biosimilar Monoclonal Antibody Market size is expected to account for a considerable growth rate between 2023 to 2032.

Leading players in Japan Biosimilar Monoclonal Antibody Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.

End User segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Australia Biosimilar Monoclonal Antibody Market due to the outbreak of COVID-19.

India Biosimilar Monoclonal Antibody Market is projected to experience high investment on various major technologies/product/services in India country by the end of 2032 owing to presence of key end user vertical adopting offerings at a faster pace.

The LAMEA Biosimilar Monoclonal Antibody Market achieved significant revenue share in base year of analysis. The LAMEA Biosimilar Monoclonal Antibody Market size is expected to account for a considerable growth rate between 2023 to 2032.

The End User segment in Brazil Biosimilar Monoclonal Antibody Market is expected to garner considerable share in terms of value and volume during the forecast period.